Kimmo Salminen
- Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial (2026)
- Lancet Gastroenterology and Hepatology
- First local results of the Finnish FIT-based colorectal cancer screening program - high yield, low complications (2025)
- Scandinavian Journal of Gastroenterology
- Maksakirroosi. Käypä hoito -suositus (2025) Maksakirroosi. Käypä hoito -suositus Arkkila, Perttu; Nordin, Arno; Arola, Johanna; Lempiäinen, Anna; Majuri, Minna; Mervaala, Eero; Männistö, Ville; Parviainen, Helka; Ronkainen, Jukka; Salminen, Kimmo; Åberg, Fredrik
- Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease (2025)
- Digestive Diseases and Sciences
- Paksusuolisyövän seulonta toi esiin tähystysten tarpeen (2024)
- Lääkärilehti
- Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease (2024)
- European Journal of Gastroenterology and Hepatology
- Maksansiirtopotilailla on hyvä pitkän aikavälin ennuste Varsinais-Suomessa (2023)
- Lääkärilehti
- Severe ulcerative proctitis, pyoderma gangrenosum, hidradenitis suppurativa and fever in a patient with a rare variant of the PSTPIP1 gene (2021)
- Clinical and Experimental Dermatology
- High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab–a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO) (2018)
- Scandinavian Journal of Gastroenterology